NHS Data Shows Under-55s Less Likely to Complete Bowel Screening

Newly released annual data has prompted NHS England to draw attention to a participation gap in its bowel cancer screening programme, specifically among people in their sixth decade. The figures indicate that adults in their 50s are completing home testing kits at a notably lower rate than older cohorts.

According to the latest screening statistics, which cover the period from April 2024 to March 2025, the uptake rate among 54-year-olds reached 56.2%. This represents just over half of the eligible population in that single-year age band returning a completed faecal immunochemical test (FIT) kit.

The national programme, which mails FIT kits to the homes of eligible individuals, is designed to detect early signs of bowel cancer before symptoms develop. NHS England confirmed that the initiative currently finds around 100 cancers a week, underscoring the diagnostic yield of widespread screening.

Uptake Patterns by Age

While the overall programme performance has shown improvement over successive years, a downward trend in participation among the newly eligible and younger age groups has become a clear focal point. The 56.2% completion rate for 54-year-olds presents a contrast with participation patterns historically observed in older bands, though direct older-age comparisons were not detailed in the most recent release. The health body has framed the lower uptake in the 50s demographic as a key concern, given that the risk of developing bowel cancer increases with age.

The screening programme was progressively expanded in recent years, with eligibility now starting at age 54 in many parts of the country, and a full roll-out to everyone aged 50 to 74 being implemented. The FIT kit requires a small stool sample to be taken at home and returned via a prepaid postal service for laboratory analysis, which looks for minute traces of blood.

Scale of Detection

The detection rate of approximately 100 cancers each week positions the NHS Bowel Cancer Screening Programme as one of the service's most consequential early diagnosis pathways. Bowel cancer remains one of the most prevalent cancer types in England, but survival rates are significantly improved when the disease is identified at stage one or two, outcomes that are more common through screening than through symptomatic presentation.

The programme also allows for the identification and removal of pre-cancerous polyps via subsequent colonoscopy, effectively preventing cancers from developing in the first instance. NHS England noted that thousands of polyps are removed annually as a direct result of these home test completions.

The new participation data for 54-year-olds was drawn from the most recent annual bowel screening report, which collates regional and demographic measures from across the country. While the national cumulative figures fluctuate, the 56.2% metric represents a snapshot of behaviour among those who have only recently become eligible for the programme, and whom the health service is keen to engage early and consistently.